Compare FMC Corp (FMC) vs Linde PLC (LIN) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

Linde (LIN) trades at $522.54, down 0.29% on the day, with a bullish technical signal from moving averages and oversold RSI suggesting potential rebound. The company demonstrates strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $4.33 (beat), and robust profitability with a 20.44% net margin. Recent news highlights sustainability leadership and Q1 results showing 10% EPS growth.

Outlook remains positive given analyst consensus (85.7% buy ratings) and a $560 price target, though high valuation multiples (P/E 34.65) pose a risk if growth moderates. Key risks include rising debt-to-asset ratio (31.63% in 2025) and macroeconomic pressures on industrial demand.